Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 283 (RN7SKP283) is classified as a pseudogene, specifically a non-coding RNA gene that is related to, but distinct from, the functional RN7SK (7SK small nuclear RNA) gene. Pseudogenes typically do not code for functional RNA or protein products, and there is no evidence linking RN7SKP283 to specific molecular interactions, drug targets, or disease associations. In contrast, the canonical 7SK RNA is a regulatory non-coding RNA that controls transcription elongation in cells, but pseudogenes like RN7SKP283 are generally not involved in such essential cellular or disease processes. RN7SK pseudogene 283 is annotated as a pseudogene in human genomic databases with no established biological or therapeutic relevance. There is no data to support RN7SKP283 acting as a therapeutic target or functioning as a receptor, enzyme, transporter, or other target class. The true 7SK small nuclear RNA plays a pivotal role in regulating RNA polymerase II transcription elongation and mRNA production in cooperation with protein complexes such as P-TEFb and HEXIM1. However, the pseudogene version RN7SKP283 does not participate in or regulate these pathways. No known disease associations or drug interactions are reported for RN7SKP283. The entry for "RN7SK pseudogene 283" is not a therapeutic or functional target but a genomic pseudogene with no known biological activity, drug interactions, or disease associations. If you need details about the actual functional RNA (7SK snRNA), please clarify, as that is a well-characterized regulatory non-coding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 283 (RN7SKP283).